Plain-English translation of NCT04234971 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a newer bone graft material called Demineralized Bone Matrix with Bone Morphogenic Protein (DBM/BMP) works as well as the traditional approach of using bone taken from a patient's own hip. Researchers want to know if the newer material is more affordable, causes less pain after surgery, and heals just as well as the traditional method.
The traditional bone graft method requires surgeons to remove bone from a patient's hip, which means more surgery and more pain. This trial exists to see if a newer manufactured material could give patients the same healing results without the extra surgery and discomfort.
You likely qualify if…
You likely don't qualify if…
If you qualify and join this trial, you will be randomly assigned to receive one of two bone grafting methods during your alveolar bone graft surgery. Your surgical team will either use the newer material (DBM/BMP) or the traditional bone graft from your hip. After surgery, the research team will track your pain levels, how quickly you heal, and the total cost of your care to compare the two approaches.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States